Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes.
Priya PrahaladM TanenbaumK HoodDavid M MaahsPublished in: Diabetic medicine : a journal of the British Diabetic Association (2018)
With the evolution of diabetes technology, those living with Type 1 diabetes are given a wider arsenal of tools with which to achieve glycaemic control and improve patient-reported outcomes. Furthermore, the use of these technologies may help reduce the risk of acute complications, such as severe hypoglycaemia and diabetic ketoacidosis, as well as long-term macro- and microvascular complications. In addition, diabetes technology can have a beneficial impact on psychosocial health by reducing the burden of diabetes. Unfortunately, diabetes goals are often unmet and people with Type 1 diabetes too frequently experience acute and long-term complications of this condition, in addition to often having less than ideal psychosocial outcomes. Increasing realization of the importance of patient-reported outcomes is leading to diabetes care delivery becoming more patient-centred. Diabetes technology in the form of medical devices, digital health and big data analytics have the potential to improve clinical care and psychosocial support, resulting in lower rates of acute and chronic complications, decreased burden of diabetes care, and improved quality of life.
Keyphrases
- patient reported outcomes
- type diabetes
- glycemic control
- cardiovascular disease
- big data
- healthcare
- mental health
- risk factors
- liver failure
- public health
- drug induced
- respiratory failure
- palliative care
- artificial intelligence
- machine learning
- insulin resistance
- intensive care unit
- hepatitis b virus
- social media
- human health
- skeletal muscle
- metabolic syndrome
- extracorporeal membrane oxygenation